Fidelity Investments’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History

Fidelity Investments’s Portfolio SGTX Stock Details SGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-78,796	Closed	-$1.77M	–	5665
2023 Q2	$1.77M	Sell	78,796 -2,327	-3%	-$16.9K	﹤0.01%	2349
2023 Q1	$981K	Sell	81,123 -455	-0.6%	-$4.73K	﹤0.01%	2531
2022 Q4	$371K	Sell	81,578 -214	-0.3%	-$1.22K	﹤0.01%	2816
2022 Q3	$537K	Sell	81,792 -254	-0.3%	-$2.32K	﹤0.01%	2761
2022 Q2	$885K	Sell	82,046 -56	-0.1%	-$753	﹤0.01%	2707
2022 Q1	$1.57M	Sell	82,102 -106	-0.1%	-$2.36K	﹤0.01%	2675
2021 Q4	$2.95M	Buy	82,208 +10,536	+15%	+$600K	﹤0.01%	2481
2021 Q3	$5.26M	Buy	71,672 +12,210	+21%	+$940K	﹤0.01%	2352
2021 Q2	$8.29M	Sell	59,462 -2,938	-5%	-$516K	﹤0.01%	2180
2021 Q1	$18.1M	Sell	62,400 -11,015	-15%	-$4.38M	﹤0.01%	1838
2020 Q4	$45.8M	Buy	+73,415	New	+$33.3M	﹤0.01%	1352

Other funds holding SGTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Fidelity Investments's SGTX Position: Q3 2023 in Review

Fidelity Investments sold out of Sigilon Therapeutics, Inc. Common Stock (SGTX) in Q3 2023, closing a stake of 78,796 shares — an estimated $1.77M sold.

Fidelity Investments first reported a position in SGTX in Q4 2020 and held it in 11 quarters. The position peaked at $45.8M in Q4 2020. 1 fund tracked by Wall St. Rank holds SGTX as of Q3 2023.

Fidelity Investments reported no remaining Sigilon Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Fidelity Investments sold 78,796 Sigilon Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $1.77M.
Fidelity Investments first reported a position in Sigilon Therapeutics, Inc. Common Stock in Q4 2020 and held it in 11 quarters.
Fidelity Investments's Sigilon Therapeutics, Inc. Common Stock position peaked at $45.8M in Q4 2020.
1 fund tracked by Wall St. Rank held Sigilon Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Fidelity Investments's 13F filing for Q3 2023, filed 13 Nov 2023.